Señales en vivo de GLTO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.08% compare to its pairs and should correct upwards.

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases...

Stats
Volumen de hoy	35 948
Volumen promedio	161 524
Capitalización de mercado	13.29M
EPS	$-0.200 ( Q1 \| 2024-04-29 )
Próxima fecha de ganancias	( $-0.320 ) 2024-07-29
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.430 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00400 (0.82%)

AADI -5.88%

ABCL 2.20%

ABCM 0.04%

ABEO -3.08%

ABIO -2.77%

ABOS 0.93%

ABSI 4.42%

ABUS -1.31%

ABVX -2.56%

ACAD -0.64%

ACER -17.95%

ACET -8.84%

ACGN 1.29%

ACHL -2.89%

ACHV 2.59%

ACIU -1.00%

ACLX -0.24%

ACRV -4.29%

ACST -3.58%

ACXP 3.23%

ADAG 7.14%

ADAP -3.97%

ADGI 0.87%

ADIL -3.51%

ADMA -1.54%

ADPT 0.59%

ADTX -3.47%

ADVM 1.01%

ADXN -1.60%

AEON -5.61%

AEZS -2.19%

AFMD -2.62%

AGEN -4.44%

AGIO -2.98%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 7.94%

AKRO -2.43%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.40%

ALEC -0.92%

ALGS -1.09%

ALKS 1.61%

ALLK -10.17%

ALLO -2.50%

ALLR -3.37%

ALNA 3.16%

ALNY 2.09%

ALPN 0.02%

ALPX 0.00%

ALRN -3.00%

ALT -15.59%

ALVR -1.65%

ALXN 0.00%

ALXO -10.50%

ALZN -1.05%

AMRN -4.13%

AMTI -3.13%

ANAB 1.55%

ANEB 7.20%

ANGN 0.00%

ANIX -4.05%

ANL -0.14%

ANNX 1.53%

ANPC -3.15%

APGE 2.08%

APGN 8.48%

APGNW 30.65%

APLM -6.42%

APLS 0.07%

APLT 0.45%

APM 0.21%

APOP 0.38%

APRE -3.13%

APTO 2.55%

APTX 3.17%

APVO 3.35%

ARAV -13.39%

ARCT -6.81%

ARDS -12.13%

ARDX 1.50%

ARGX -1.26%

ARNA 0.00%

ARPO -0.90%

ARQT -3.23%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.76%

ARWR -2.27%

ASLN -2.23%

ASMB -7.14%

ASND -2.31%

ATAI -3.70%

ATHA 10.05%

ATHE 0.08%

ATHX -33.50%

ATNF 0.99%

ATOS 1.94%

ATRA -6.23%

ATXI 1.94%

ATXS -0.33%

AUPH -1.08%

AURA 4.70%

AUTL -3.45%

AVBP -3.03%

AVEO 0.00%

AVIR -1.75%

AVRO -1.41%

AVTE -0.69%

AVTX -4.26%

AVXL -5.68%

AXLA 0.00%

AXSM -2.39%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.77%

BCAB -7.84%

BCDA -1.02%

BCDAW -46.41%

BCEL 0.00%

BCLI -0.18%

BCRX 1.64%

BCTX 12.76%

BCTXW 11.64%

BCYC 0.95%

BDRX -4.42%

BDTX 0.00%

BEAM 2.43%

BFRA -2.91%

BGNE -3.01%

BIOR -5.65%

BIVI 1.72%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.45%

BLTE -1.65%

BLU 0.03%

BLUE -4.28%

BMEA -14.59%

BMRN 0.33%

BNOX 4.44%

BNTC -5.76%

BNTX -2.20%

BOLD -9.71%

BOLT -1.36%

BPMC -2.47%

BPTH -6.67%

BPTS -13.47%

BRNS -0.37%

BRTX -4.72%

BTAI 11.86%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 0.48%

CADL 1.06%

CALA 0.00%

CALC -8.27%

CALT -1.87%

CAPR -0.22%

CARA -12.44%

CARM 6.09%

CASI -1.24%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.67%

CCCC -1.70%

CCXI 0.00%

CDAK 0.00%

CDIO -4.74%

CDIOW -28.57%

CDMO -1.27%

CDMOP 0.04%

CDT -13.82%

CDTTW -39.60%

CDTX -6.28%

CDXC 9.43%

CDXS 9.66%

CELC -2.79%

CELU -1.00%

CELUW -15.56%

CERC -1.68%

CERE -1.52%

CERO -4.60%

CEROW -20.36%

CFRX -27.95%

CGEM 0.49%

CGEN -3.31%

CGON -2.90%

CGTX -3.41%

CHMA -6.00%

CHRS 5.06%

CINC 0.00%

CING -3.75%

CINGW 34.95%

CKPT -0.96%

CLBS -16.75%

CLDX -0.28%

CLGN -0.60%

CLLS -3.11%

CLNN -2.47%

CLNNW 0.00%

CLRB 7.04%

CLSD -3.20%

CLSN -0.68%

CLVS 0.00%

CMMB -1.96%

CMND 3.23%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -35.21%

CNST 0.00%

CNTA 1.12%

CNTB 0.00%

CNTX -9.59%

COCP -2.40%

COEPW 32.45%

COGT -2.64%

CORT 3.98%

COYA -2.60%

CPRX -0.46%

CRBP -1.94%

CRBU -7.95%

CRDF 3.54%

CRGX -2.01%

CRIS -4.34%

CRNX -5.97%

CRSP 1.22%

CRTX 2.63%

CRVO -7.90%

CRVS 0.56%

CSBR -3.50%

CTCX -11.20%

CTIC 0.06%

CTMX 0.00%

CTNM 4.37%

CTXR -7.15%

CUE -4.50%

CVAC -4.94%

CVKD -1.26%

CWBR 2.80%

CYAD -12.96%

CYCC 19.53%

CYCCP 6.99%

CYCN 7.81%

CYT -2.27%

CYTK -2.12%

CYTO 0.91%

DARE -0.30%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 30.97%

DNLI -1.74%

DNTH -2.27%

DOMH -1.06%

DRMA -3.31%

DRMAW -1.25%

DRNA 0.00%

DRTS 2.31%

DRTSW -8.92%

DRUG -0.10%

DSGN -2.42%

DTIL 1.04%

DYAI 9.68%

EARS -1.77%

EDIT -3.22%

EDSA 4.14%

EFTR -3.93%

EFTRW -55.56%

EIGR -9.21%

ELAB -2.41%

ELDN 6.72%

ELEV -2.49%

ELOX 6.15%

ELTX -5.29%

ELVN -1.35%

ELYM 10.04%

ENGN -1.23%

ENGNW -22.50%

ENLV -0.72%

ENOB 1.79%

ENSC 6.53%

ENTA -0.33%

ENTO -4.97%

ENTX 1.60%

ENVB 3.10%

EPIX 2.89%

EPRX -2.87%

EPZM 0.00%

EQ -1.14%

EQRX -2.09%

EQRXW 0.00%

ERAS 5.77%

ERNA -1.11%

ERYP 1.30%

ESLA -1.08%

ESLAW 1.62%

ETNB -7.00%

ETON 2.44%

ETTX 0.00%

EVAX 1.42%

EVGN 2.16%

EVLO 0.00%

EWTX 0.52%

EXAI 0.19%

EXEL 0.54%

EYEG -0.67%

EYEN -3.08%

EYPT -0.85%

FATE -12.37%

FBIO 0.59%

FBIOP 0.87%

FBLG -10.20%

FBRX -0.04%

FDMT -4.50%

FENC -2.90%

FGEN -9.83%

FHTX 5.34%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.72%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 3.18%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.45%

GANX -2.31%

GBIO -1.06%

GBT 0.01%

GDTC 2.03%

GERN -1.55%

GHRS -4.10%

GLMD -2.48%

GLPG -1.91%

GLSI 11.18%

GLTO -3.90%

GLUE -2.64%

GLYC -12.60%

GMAB -0.43%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -4.87%

GNPX -3.92%

GNTA 3.94%

GOSS -7.00%

GOVX -8.41%

GOVXW 10.89%

GPCR -5.21%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.78%

GRTX 2.19%

GTHX 2.27%

GUTS 0.69%

GXGXW 41.67%

GYRE -5.65%

HALO -0.76%

HARP 0.09%

HCWB -7.15%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK 0.00%

HOTH -2.86%

HOWL 0.00%

HRMY 3.32%

HRTX 9.18%

HSTO 0.00%

HUMA 1.42%

HUMAW -6.25%

IBRX -6.88%

ICCC -0.44%

ICPT 0.21%

ICU 18.87%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.43%

IFRX -1.23%

IGMS -2.05%

IKNA -2.38%

IKT 0.00%

IMAB -0.87%

IMCR -4.15%

IMGN 0.02%

IMGO 0.00%

IMMP 5.32%

IMMX -5.17%

IMNM 4.25%

IMNN -1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.50%

IMTX -1.50%

IMTXW 6.00%

IMUX -9.19%

IMV 0.00%

IMVT -4.51%

INAB -1.80%

INBX -3.11%

INCY -2.14%

INDP 8.72%

INFI -52.38%

INKT 0.00%

INM 0.77%

INMB 1.96%

INO 1.56%

INSM -1.05%

INTS -3.14%

INVA 0.87%

INZY 1.14%

IOBT -7.09%

IONS 1.49%

IOVA -4.02%

IPA 0.50%

IPHA 2.54%

IPSC -3.91%

IRON -2.47%

ISEE 0.38%

ITOS 2.87%

ITRM 1.67%

IVA 6.96%

IVVD 0.00%

JAGX 1.31%

JANX -4.03%

JAZZ -0.85%

JNCE 0.00%

JSPR -1.50%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.96%

KALV -2.08%

KDNY 0.22%

KMPH -0.34%

KNSA -2.32%

KNTE -0.38%

KOD -9.49%

KPRX -4.08%

KPTI -8.71%

KRBP -10.00%

KRON 0.74%

KROS -0.22%

KRRO 0.09%

KRTX 0.03%

KRYS 0.82%

KTRA 9.55%

KTTA -0.65%

KTTAW 82.57%

KURA 0.54%

KYMR -4.04%

KYTX -6.07%

KZIA 4.51%

KZR -3.84%

LABP 0.57%

LBPH 1.57%

LBPS 0.00%

LBPSW 14.81%

LEGN 3.15%

LENZ -3.67%

LEXX 0.77%

LEXXW 23.81%

LGND -1.37%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -9.42%

LIXT -9.81%

LIXTW 45.97%

LJPC -0.32%

LMNL 0.12%

LOGC 0.52%

LPCN -3.68%

LPTX -3.30%

LQDA 0.33%

LRMR -0.21%

LSTA -1.16%

LTRN 6.48%

LUMO 0.67%

LVTX -4.64%

LXEO -13.22%

LXRX -1.18%

LYEL -36.03%

LYRA 3.49%

MACK 0.10%

MBIO -11.26%

MBRX -1.43%

MCRB 0.05%

MDGL -1.67%

MDNA -13.16%

MDWD 4.25%

MDXG -1.77%

MEIP 0.00%

MESO -1.48%

MGNX -5.13%

MGTA -7.74%

MGTX 0.00%

MGX 1.88%

MIRM -0.84%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -6.54%

MLECW 3.08%

MLND -5.36%

MLTX 1.23%

MLYS -8.87%

MNKD -0.95%

MNMD 2.83%

MNOV 0.70%

MNPR -9.09%

MOLN 0.76%

MOR 0.45%

MORF -3.16%

MREO -0.29%

MRKR 1.50%

MRNA -11.01%

MRNS -7.35%

MRSN -3.81%

MRTX -0.17%

MRUS 0.37%

MRVI 1.02%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.95%

MYMD 2.16%

NAMS 0.41%

NAMSW 0.64%

NAUT -1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 10.66%

NCNA -1.45%

NERV -0.32%

NEXI 1.47%

NGM -1.28%

NGNE 2.93%

NKGN 9.24%

NKGNW -20.91%

NKTR 1.40%

NKTX -2.61%

NLSP 7.41%

NLSPW 26.67%

NMRA -1.71%

NMTR -42.97%

NOVN -24.84%

NRBO 13.38%

NRIX -1.63%

NRSN 2.60%

NRSNW 0.00%

NRXP -10.41%

NRXPW 18.33%

NRXS 1.20%

NTBL 2.67%

NTEC -12.45%

NTHI 0.00%

NTLA -4.54%

NTRBW -31.07%

NUVL -1.98%

NVAX -6.36%

NVCT -8.45%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 2.37%

OABIW 2.60%

OBIO 0.15%

OBSV 0.00%

OCEA -3.52%

OCGN 8.47%

OCS 0.25%

OCUL 1.07%

OCUP 0.33%

ODT -4.27%

OKYO 1.72%

OLMA -5.71%

OMER -1.80%

OMGA -2.08%

ONCO 9.93%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.97%

ONTX -0.47%

ONVO 1.00%

OPNT 0.00%

OPT -3.09%

ORGS 1.65%

ORIC -1.63%

ORMP 14.73%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.69%

OVID 1.80%

OYST 0.00%

PALI -0.43%

PASG 0.00%

PBLA -7.50%

PBM -3.26%

PBYI 6.08%

PCSA -0.97%

PCVX 0.74%

PDSB -3.80%

PEPG 0.89%

PGEN -7.19%

PHAR 1.99%

PHAS 0.00%

PHAT -1.06%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.55%

PHXM -5.20%

PIRS 0.11%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -3.11%

PLUR 10.43%

PMN -5.55%

PMVP -1.19%

PNT 0.16%

PPBT 2.13%

PRAX 6.33%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 1.79%

PRQR -0.60%

PRTA -3.90%

PRTC -2.46%

PRTG 0.09%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.37%

PSTX -4.26%

PTCT -0.37%

PTE -0.82%

PTGX 0.16%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.90%

QLGN -7.17%

QNCX 2.04%

QNRX -1.34%

QSI -28.31%

QSIAW -9.50%

QTTB 4.94%

QURE -1.35%

RAIN -1.63%

RANI 4.01%

RAPT -0.97%

RARE 1.71%

RCKT -10.73%

REGN -0.19%

RENB -2.48%

REPL -1.25%

RETA 0.02%

REUN -0.89%

REVB -7.44%

REVBU 3.46%

REVBW 4.38%

RGLS -4.67%

RGNX -6.57%

RIGL -6.24%

RLAY -7.12%

RLMD 0.00%

RLYB -6.04%

RNA 2.46%

RNAC 2.87%

RNAZ -0.96%

RNXT 0.89%

ROIV -2.40%

ROIVW 4.56%

RPHM -2.48%

RPRX -1.19%

RPTX -1.17%

RUBY 2.70%

RVLP -32.05%

RVMD -1.06%

RVMDW -30.00%

RVNC -0.43%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.61%

RYTM -6.74%

RYZB 0.02%

RZLT 3.36%

SABS -3.41%

SABSW -5.53%

SAGE -0.55%

SANA -3.14%

SAVA -3.78%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 3.56%

SCPH 12.12%

SCPS 0.00%

SEEL -2.79%

SEER -1.76%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -5.19%

SGMT -4.83%

SGTX -2.56%

SIOX 22.63%

SLDB -1.72%

SLGL 5.23%

SLN -8.22%

SLNO 1.59%

SLRX 0.40%

SLS -4.27%

SMMT -3.00%

SNDX 1.74%

SNGX 3.02%

SNPX -2.77%

SONN 0.20%

SPPI -0.49%

SPRB -1.64%

SPRC -2.99%

SPRO 0.00%

SRNE 0.00%

SRPT -0.73%

SRRA 0.00%

SRRK -2.85%

SRZN 6.13%

STAB 0.00%

STOK -7.38%

STRO -1.84%

STSA 0.00%

STTK 6.61%

SURF -0.93%

SVRA 1.05%

SWTX -0.49%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -6.90%

TARS -2.13%

TBPH 0.12%

TCBP 8.77%

TCDA 0.00%

TCON -2.03%

TCRR 0.00%

TCRT -1.21%

TCRX -1.29%

TECH -1.33%

TENX -0.32%

TERN -8.00%

TFFP -12.18%

TGTX -7.61%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.41%

TNGX -4.21%

TNXP -10.00%

TNYA -4.73%

TPST 4.85%

TRDA -4.54%

TRVI 1.53%

TRVN 2.74%

TSHA -17.24%

TSVT -4.26%

TTNP -6.21%

TVTX 3.64%

TYRA -6.95%

UBX -2.13%

UNCY -4.00%

URGN 4.18%

UTHR -0.03%

VACC 11.36%

VALN -3.15%

VAXX 113.13%

VBIV -0.78%

VBLT -8.77%

VCEL 1.94%

VCNX 5.26%

VCYT -1.01%

VERA -4.29%

VERU 0.54%

VERV -4.02%

VIGL 1.61%

VINC 2.81%

VIR -1.30%

VIRI -4.25%

VIRX -1.75%

VKTX -0.86%

VLON -13.04%

VNDA -2.61%

VOR -7.26%

VRCA 0.14%

VRDN -3.53%

VRNA -2.33%

VRPX -0.48%

VRTX 0.04%

VSTM 4.42%

VTGN -2.11%

VTVT -0.18%

VTYX -2.93%

VXRT -2.09%

VYGR -0.26%

VYNE -7.51%

VYNT 7.78%

WINT -2.72%

WVE -8.28%

XBIO 1.03%

XBIT 1.88%

XCUR 1.26%

XENE -1.16%

XERS 4.76%

XFOR 4.17%

XLO 1.33%

XLRN 0.00%

XNCR 0.41%

XOMA -7.75%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.72%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.97%

ZNTL -0.95%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-20	Prener Anne	Buy	18 000	Stock Option (right to buy)
2024-06-20	Munshi Amit	Buy	18 000	Stock Option (right to buy)
2024-06-20	Goldfischer Carl	Buy	36 000	Stock Option (right to buy)
2024-06-20	Shapiro David	Buy	18 000	Stock Option (right to buy)
2024-06-20	Dallas Jayson Donald Alexander	Buy	18 000	Stock Option (right to buy)

INSIDER POWER
-7.33
Last 97 transactions
Buy: 3 330 854 \| Sell: 1 504 628

Correlación (AI algo v.1.1b): Undervalued: 0.08% $0.490 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: 0.02 (neutral)

Corto: 0.00 (neutral)

Signal:(42.568) Neutral

Galecto, Inc. Correlación

10 Correlaciones Más Positivas
NVNO	0.836

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Galecto, Inc. Correlación - Moneda/Commodity

0.72
( moderate )

0.51
( weak )

0.00
( neutral )

0.55
( weak )

Galecto, Inc. Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-830 000 (0.00 %)
EPS:	$-1.440

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-830 000 (0.00 %)
EPS:	$-1.440

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-490 000 (0.00 %)
EPS:	$-2.44

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.05

Financial Reports:

No articles found.

Galecto, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Galecto, Inc.

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts.